Development of Manufacturing Therapeutic Platform for EVs Derived from MSC using TFDF and TFF
There has been a growing demand in Extracellular Vesicle (EV) supply in recent years due to their emerging role as intercellular messengers and their therapeutic potential as targeted and natural drug delivery vehicles with high specificity and efficiency